| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| RMD - ResMed Inc | HOLD | 0 @ USD 246.88 | USD 0 | The current share valuation price of RMD based on adjusted close was USD 246.88. The average price that RMD shares were previous bought at was USD 244.817. The current market price is 0.8% higher than average price they were purchased at. The value of the holding in RMD has fallen by USD 110,392 compared to the previous valuation of ResMed Inc |
| LMAT - LeMaitre Vascular Inc | HOLD | 0 @ USD 86.6099 | USD 0 | The current share valuation price of LMAT based on adjusted close was USD 86.6099. The average price that LMAT shares were previous bought at was USD 88.5943. The current market price is -2.2% lower than average price they were purchased at. The value of the holding in LMAT has fallen by USD 5,774 compared to the previous valuation of LeMaitre Vascular Inc |
| MASI - Masimo Corporation | HOLD | 0 @ USD 140.65 | USD 0 | The current share valuation price of MASI based on adjusted close was USD 140.65. The average price that MASI shares were previous bought at was USD 155.136. The current market price is -9.3% lower than average price they were purchased at. The value of the holding in MASI has fallen by USD 5,760 compared to the previous valuation of Masimo Corporation |
| MDT - Medtronic PLC | HOLD | 0 @ USD 90.7 | USD 0 | The current share valuation price of MDT based on adjusted close was USD 90.7. The average price that MDT shares were previous bought at was USD 89.3942. The current market price is 1.5% higher than average price they were purchased at. The value of the holding in MDT has fallen by USD 48,477 compared to the previous valuation of Medtronic PLC |
| NVCR - Novocure Ltd | HOLD | 0 @ USD 12.81 | USD 0 | The current share valuation price of NVCR based on adjusted close was USD 12.81. The average price that NVCR shares were previous bought at was USD 17.9917. The current market price is -28.8% lower than average price they were purchased at. The value of the holding in NVCR has fallen by USD 143 compared to the previous valuation of Novocure Ltd |
| NVST - Envista Holdings Corp | HOLD | 0 @ USD 20.35 | USD 0 | The current share valuation price of NVST based on adjusted close was USD 20.35. The average price that NVST shares were previous bought at was USD 19.1014. The current market price is 6.5% higher than average price they were purchased at. The value of the holding in NVST has increased by USD 4,961 compared to the previous valuation of Envista Holdings Corp however if the holding was sold on 2025-10-31 this would crystalise an overall loss. |
| OFIX - Orthofix Medical Inc | HOLD | 0 @ USD 15.44 | USD 0 | The current share valuation price of OFIX based on adjusted close was USD 15.44. The average price that OFIX shares were previous bought at was USD 15.4195. The current market price is 0.1% higher than average price they were purchased at. The value of the holding in OFIX has fallen by USD 155 compared to the previous valuation of Orthofix Medical Inc |
| OMCL - Omnicell Inc | HOLD | 0 @ USD 33.57 | USD 0 | The current share valuation price of OMCL based on adjusted close was USD 33.57. The average price that OMCL shares were previous bought at was USD 34.6329. The current market price is -3.1% lower than average price they were purchased at. The value of the holding in OMCL has fallen by USD 65 compared to the previous valuation of Omnicell Inc |
| PEN - Pennant International Group plc | HOLD | 0 @ USD 227.37 | USD 0 | The current share valuation price of PEN based on adjusted close was USD 227.37. The average price that PEN shares were previous bought at was USD 259.747. The current market price is -12.5% lower than average price they were purchased at. The value of the holding in PEN has fallen by USD 22,705 compared to the previous valuation of Pennant International Group plc |
| PEN - PBF Energy Inc | HOLD | 0 @ USD 227.37 | USD 0 | The current share valuation price of PEN based on adjusted close was USD 227.37. The average price that PEN shares were previous bought at was USD 259.747. The current market price is -12.5% lower than average price they were purchased at. The value of the holding in PEN has fallen by USD 22,705 compared to the previous valuation of PBF Energy Inc |
| PODD - Insulet Corporation | HOLD | 0 @ USD 313.01 | USD 0 | The current share valuation price of PODD based on adjusted close was USD 313.01. The average price that PODD shares were previous bought at was USD 292.47. The current market price is 7.0% higher than average price they were purchased at. The value of the holding in PODD has increased by USD 10,479 compared to the previous valuation of Insulet Corporation however if the holding was sold on 2025-10-31 this would crystalise an overall loss. |
| PRCT - Procept Biorobotics Corp | HOLD | 0 @ USD 34.03 | USD 0 | The current share valuation price of PRCT based on adjusted close was USD 34.03. The average price that PRCT shares were previous bought at was USD 59.9589. The current market price is -43.2% lower than average price they were purchased at. The value of the holding in PRCT has fallen by USD 2,720 compared to the previous valuation of Procept Biorobotics Corp |
| QDEL - Quidel Corporation | HOLD | 0 @ USD 26.99 | USD 0 | The current share valuation price of QDEL based on adjusted close was USD 26.99. The average price that QDEL shares were previous bought at was USD 34.4553. The current market price is -21.7% lower than average price they were purchased at. The value of the holding in QDEL has increased by USD 1,729 compared to the previous valuation of Quidel Corporation however if the holding was sold on 2025-10-31 this would crystalise an overall loss. |
| LIVN - LivaNova PLC | HOLD | 0 @ USD 52.63 | USD 0 | The current share valuation price of LIVN based on adjusted close was USD 52.63. The average price that LIVN shares were previous bought at was USD 46.565. The current market price is 13.0% higher than average price they were purchased at. The value of the holding in LIVN has fallen by USD 1,208 compared to the previous valuation of LivaNova PLC |
| SIBN - Si-Bone Inc | HOLD | 0 @ USD 14.8299 | USD 0 | The current share valuation price of SIBN based on adjusted close was USD 14.8299. The average price that SIBN shares were previous bought at was USD 15.3586. The current market price is -3.4% lower than average price they were purchased at. The value of the holding in SIBN has fallen by USD 1,643 compared to the previous valuation of Si-Bone Inc |
| SRDX - SurModics Inc | HOLD | 0 @ USD 27.435 | USD 0 | The current share valuation price of SRDX based on adjusted close was USD 27.435. The average price that SRDX shares were previous bought at was USD 30.7598. The current market price is -10.8% lower than average price they were purchased at. The value of the holding in SRDX has increased by USD 521 compared to the previous valuation of SurModics Inc however if the holding was sold on 2025-10-31 this would crystalise an overall loss. |
| STE - STERIS plc | HOLD | 0 @ USD 235.7 | USD 0 | The current share valuation price of STE based on adjusted close was USD 235.7. The average price that STE shares were previous bought at was USD 229.396. The current market price is 2.7% higher than average price they were purchased at. The value of the holding in STE has fallen by USD 6,763 compared to the previous valuation of STERIS plc |
| SYK - Stryker Corporation | HOLD | 0 @ USD 356.24 | USD 0 | The current share valuation price of SYK based on adjusted close was USD 356.24. The average price that SYK shares were previous bought at was USD 375.231. The current market price is -5.1% lower than average price they were purchased at. The value of the holding in SYK has fallen by USD 614,285 compared to the previous valuation of Stryker Corporation |
| TFX - Teleflex Incorporated | HOLD | 0 @ USD 124.47 | USD 0 | The current share valuation price of TFX based on adjusted close was USD 124.47. The average price that TFX shares were previous bought at was USD 142.8. The current market price is -12.8% lower than average price they were purchased at. The value of the holding in TFX has fallen by USD 2,291 compared to the previous valuation of Teleflex Incorporated |
| TMCI - Treace Medical Concepts Inc | HOLD | 0 @ USD 6.39 | USD 0 | The current share valuation price of TMCI based on adjusted close was USD 6.39. The average price that TMCI shares were previous bought at was USD 7.63756. The current market price is -16.3% lower than average price they were purchased at. The value of the holding in TMCI has increased by USD 243 compared to the previous valuation of Treace Medical Concepts Inc however if the holding was sold on 2025-10-31 this would crystalise an overall loss. |
| TMDX - TransMedics Group Inc | HOLD | 0 @ USD 131.54 | USD 0 | The current share valuation price of TMDX based on adjusted close was USD 131.54. The average price that TMDX shares were previous bought at was USD 92.4191. The current market price is 42.3% higher than average price they were purchased at. The value of the holding in TMDX has fallen by USD 20,307 compared to the previous valuation of TransMedics Group Inc |
| TNDM - Tandem Diabetes Care Inc | HOLD | 0 @ USD 14 | USD 0 | The current share valuation price of TNDM based on adjusted close was USD 14. The average price that TNDM shares were previous bought at was USD 21.1382. The current market price is -33.8% lower than average price they were purchased at. The value of the holding in TNDM has fallen by USD 5,757 compared to the previous valuation of Tandem Diabetes Care Inc |
| VREX - Varex Imaging Corp | HOLD | 0 @ USD 11.69 | USD 0 | The current share valuation price of VREX based on adjusted close was USD 11.69. The average price that VREX shares were previous bought at was USD 11.3404. The current market price is 3.1% higher than average price they were purchased at. The value of the holding in VREX has fallen by USD 894 compared to the previous valuation of Varex Imaging Corp |
| ZBH - Zimmer Biomet Holdings Inc | HOLD | 0 @ USD 100.56 | USD 0 | The current share valuation price of ZBH based on adjusted close was USD 100.56. The average price that ZBH shares were previous bought at was USD 102.401. The current market price is -1.8% lower than average price they were purchased at. The value of the holding in ZBH has increased by USD 27,723 compared to the previous valuation of Zimmer Biomet Holdings Inc however if the holding was sold on 2025-10-31 this would crystalise an overall loss. |
| EW - Edwards Lifesciences Corp | HOLD | 0 @ USD 82.45 | USD 0 | The current share valuation price of EW based on adjusted close was USD 82.45. The average price that EW shares were previous bought at was USD 72.9427. The current market price is 13.0% higher than average price they were purchased at. The value of the holding in EW has fallen by USD 84,847 compared to the previous valuation of Edwards Lifesciences Corp |
| AORT - Artivion Inc | HOLD | 0 @ USD 45.37 | USD 0 | The current share valuation price of AORT based on adjusted close was USD 45.37. The average price that AORT shares were previous bought at was USD 34.4703. The current market price is 31.6% higher than average price they were purchased at. The value of the holding in AORT has fallen by USD 1,629 compared to the previous valuation of Artivion Inc |
| ATEC - Alphatec Holdings Inc | HOLD | 0 @ USD 18.99 | USD 0 | The current share valuation price of ATEC based on adjusted close was USD 18.99. The average price that ATEC shares were previous bought at was USD 13.0979. The current market price is 45.0% higher than average price they were purchased at. The value of the holding in ATEC has increased by USD 42,491 compared to the previous valuation of Alphatec Holdings Inc however if the holding was sold on 2025-10-31 this would crystalise an overall loss. |
| ATRC - AtriCure Inc | HOLD | 0 @ USD 34.55 | USD 0 | The current share valuation price of ATRC based on adjusted close was USD 34.55. The average price that ATRC shares were previous bought at was USD 35.5195. The current market price is -2.7% lower than average price they were purchased at. The value of the holding in ATRC has increased by USD 3,198 compared to the previous valuation of AtriCure Inc however if the holding was sold on 2025-10-31 this would crystalise an overall loss. |
| AXGN - Axogen Inc | HOLD | 0 @ USD 22.2201 | USD 0 | The current share valuation price of AXGN based on adjusted close was USD 22.2201. The average price that AXGN shares were previous bought at was USD 16.1183. The current market price is 37.9% higher than average price they were purchased at. The value of the holding in AXGN has fallen by USD 2,784 compared to the previous valuation of Axogen Inc |
| BAX - Baxter International Inc | HOLD | 0 @ USD 18.47 | USD 0 | The current share valuation price of BAX based on adjusted close was USD 18.47. The average price that BAX shares were previous bought at was USD 27.7276. The current market price is -33.4% lower than average price they were purchased at. The value of the holding in BAX has fallen by USD 49,599 compared to the previous valuation of Baxter International Inc |
| BDX - Becton Dickinson and Company | HOLD | 0 @ USD 178.71 | USD 0 | The current share valuation price of BDX based on adjusted close was USD 178.71. The average price that BDX shares were previous bought at was USD 202.613. The current market price is -11.8% lower than average price they were purchased at. The value of the holding in BDX has fallen by USD 26,909 compared to the previous valuation of Becton Dickinson and Company |
| BSX - Boston Scientific Corporation | HOLD | 0 @ USD 100.72 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 100.72. The average price that BSX shares were previous bought at was USD 98.172. The current market price is 2.6% higher than average price they were purchased at. The value of the holding in BSX has increased by USD 31,147 compared to the previous valuation of Boston Scientific Corporation however if the holding was sold on 2025-10-31 this would crystalise an overall loss. |
| BSX - MULSTRXSSXIMETFP | HOLD | 0 @ USD 100.72 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 100.72. The average price that BSX shares were previous bought at was USD 98.172. The current market price is 2.6% higher than average price they were purchased at. The value of the holding in BSX has increased by USD 31,147 compared to the previous valuation of MULSTRXSSXIMETFP however if the holding was sold on 2025-10-31 this would crystalise an overall loss. |
| CNMD - CONMED Corporation | HOLD | 0 @ USD 44 | USD 0 | The current share valuation price of CNMD based on adjusted close was USD 44. The average price that CNMD shares were previous bought at was USD 56.9758. The current market price is -22.8% lower than average price they were purchased at. The value of the holding in CNMD has fallen by USD 2,105 compared to the previous valuation of CONMED Corporation |
| DXCM - DexCom Inc | HOLD | 0 @ USD 58.22 | USD 0 | The current share valuation price of DXCM based on adjusted close was USD 58.22. The average price that DXCM shares were previous bought at was USD 75.551. The current market price is -22.9% lower than average price they were purchased at. The value of the holding in DXCM has fallen by USD 548,351 compared to the previous valuation of DexCom Inc |
| ENOV - Enovis Corp | HOLD | 0 @ USD 31.24 | USD 0 | The current share valuation price of ENOV based on adjusted close was USD 31.24. The average price that ENOV shares were previous bought at was USD 36.5852. The current market price is -14.6% lower than average price they were purchased at. The value of the holding in ENOV has increased by USD 4,469 compared to the previous valuation of Enovis Corp however if the holding was sold on 2025-10-31 this would crystalise an overall loss. |
| ABT - Abbott Laboratories | HOLD | 0 @ USD 123.62 | USD 0 | The current share valuation price of ABT based on adjusted close was USD 123.62. The average price that ABT shares were previous bought at was USD 128.715. The current market price is -4.0% lower than average price they were purchased at. The value of the holding in ABT has fallen by USD 256,087 compared to the previous valuation of Abbott Laboratories |
| GEHC - GE HealthCare Technologies Inc. | HOLD | 0 @ USD 74.95 | USD 0 | The current share valuation price of GEHC based on adjusted close was USD 74.95. The average price that GEHC shares were previous bought at was USD 74.952. The current market price is 0.0% lower than average price they were purchased at. The value of the holding in GEHC has fallen by USD 3,199 compared to the previous valuation of GE HealthCare Technologies Inc. |
| GKOS - Glaukos Corp | HOLD | 0 @ USD 88.0699 | USD 0 | The current share valuation price of GKOS based on adjusted close was USD 88.0699. The average price that GKOS shares were previous bought at was USD 107.535. The current market price is -18.1% lower than average price they were purchased at. The value of the holding in GKOS has increased by USD 2,161 compared to the previous valuation of Glaukos Corp however if the holding was sold on 2025-10-31 this would crystalise an overall loss. |
| GMED - Globus Medical | HOLD | 0 @ USD 60.39 | USD 0 | The current share valuation price of GMED based on adjusted close was USD 60.39. The average price that GMED shares were previous bought at was USD 70.543. The current market price is -14.4% lower than average price they were purchased at. The value of the holding in GMED has fallen by USD 5,233 compared to the previous valuation of Globus Medical |
| HOLX - Hologic Inc | HOLD | 0 @ USD 73.91 | USD 0 | The current share valuation price of HOLX based on adjusted close was USD 73.91. The average price that HOLX shares were previous bought at was USD 66.8075. The current market price is 10.6% higher than average price they were purchased at. The value of the holding in HOLX has fallen by USD 624 compared to the previous valuation of Hologic Inc |
| IDXX - IDEXX Laboratories Inc | HOLD | 0 @ USD 629.51 | USD 0 | The current share valuation price of IDXX based on adjusted close was USD 629.51. The average price that IDXX shares were previous bought at was USD 502.42. The current market price is 25.3% higher than average price they were purchased at. The value of the holding in IDXX has increased by USD 10,874 compared to the previous valuation of IDEXX Laboratories Inc however if the holding was sold on 2025-10-31 this would crystalise an overall loss. |
| INSP - Inspirit Energy Holdings Plc | HOLD | 0 @ USD 72.0801 | USD 0 | The current share valuation price of INSP based on adjusted close was USD 72.0801. The average price that INSP shares were previous bought at was USD 136.677. The current market price is -47.3% lower than average price they were purchased at. The value of the holding in INSP has fallen by USD 3,733 compared to the previous valuation of Inspirit Energy Holdings Plc |
| IRTC - iRhythm Technologies Inc | HOLD | 0 @ USD 187.3 | USD 0 | The current share valuation price of IRTC based on adjusted close was USD 187.3. The average price that IRTC shares were previous bought at was USD 128.015. The current market price is 46.3% higher than average price they were purchased at. The value of the holding in IRTC has increased by USD 14,358 compared to the previous valuation of iRhythm Technologies Inc however if the holding was sold on 2025-10-31 this would crystalise an overall loss. |
| ISRG - Intuitive Surgical Inc | HOLD | 0 @ USD 534.28 | USD 0 | The current share valuation price of ISRG based on adjusted close was USD 534.28. The average price that ISRG shares were previous bought at was USD 508.988. The current market price is 5.0% higher than average price they were purchased at. The value of the holding in ISRG has increased by USD 213,984 compared to the previous valuation of Intuitive Surgical Inc however if the holding was sold on 2025-10-31 this would crystalise an overall loss. |
| ITGR - Integer Holdings Corp | HOLD | 0 @ USD 64.5701 | USD 0 | The current share valuation price of ITGR based on adjusted close was USD 64.5701. The average price that ITGR shares were previous bought at was USD 119.063. The current market price is -45.8% lower than average price they were purchased at. The value of the holding in ITGR has increased by USD 6,112 compared to the previous valuation of Integer Holdings Corp however if the holding was sold on 2025-10-31 this would crystalise an overall loss. |
| IART - Integra LifeSciences Holdings | SELL | -231 @ USD 12.01 | USD -2,774 | The ETF sold 231 shares of IART on 2025-10-31. The shares were previously bought for an average price of USD 18.083. The Integra LifeSciences Holdings shares were sold for -33.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,403 The average price that the ETF previously sold IART share for is USD 18.9967 which is higher than the selling price of USD 12.01 on 2025-10-31. |